Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 11.19%25.74B | 10.79%12.29B | 12.78%23.15B | 13.78%11.09B | 18.59%20.52B | 34.41%9.75B | 24.33%17.31B | 8.90%7.25B | 11.65%13.92B | 37.34%6.66B |
| Operating income | 11.19%25.74B | 10.79%12.29B | 12.78%23.15B | 13.78%11.09B | 18.59%20.52B | 34.41%9.75B | 24.33%17.31B | 8.90%7.25B | 11.65%13.92B | 37.34%6.66B |
| Cost of sales | -12.65%-18.53B | -11.16%-8.81B | -10.38%-16.45B | -10.36%-7.93B | -19.00%-14.9B | -39.82%-7.18B | -27.32%-12.52B | -13.24%-5.14B | -14.26%-9.84B | -27.40%-4.54B |
| Operating expenses | -12.65%-18.53B | -11.16%-8.81B | -10.38%-16.45B | -10.36%-7.93B | -19.00%-14.9B | -39.82%-7.18B | -27.32%-12.52B | -13.24%-5.14B | -14.26%-9.84B | -27.40%-4.54B |
| Gross profit | 7.60%7.21B | 9.85%3.47B | 19.14%6.7B | 23.37%3.16B | 17.51%5.62B | 21.24%2.56B | 17.15%4.78B | -0.40%2.11B | 5.83%4.08B | 64.80%2.12B |
| Selling expenses | 1.57%-1.03B | 3.55%-512.24M | -32.29%-1.05B | -47.58%-531.12M | 8.80%-791.91M | 20.01%-359.88M | -16.65%-868.37M | -32.21%-449.93M | -42.90%-744.43M | -71.35%-340.31M |
| Administrative expenses | -13.47%-1.86B | -8.35%-804.52M | -13.03%-1.64B | -19.17%-742.5M | -12.20%-1.45B | -13.02%-623.07M | -4.41%-1.29B | 6.29%-551.31M | -20.26%-1.24B | -37.76%-588.31M |
| Research and development expenses | -3.61%-1.5B | -1.64%-726.3M | -3.78%-1.45B | -16.08%-714.61M | -19.13%-1.4B | -21.36%-615.62M | -24.63%-1.17B | -18.67%-507.28M | -23.10%-940.7M | -70.06%-427.46M |
| Impairment and provision | 38.12%-10.13M | -30.97%-19.06M | 26.54%-16.37M | -2,755.66%-14.55M | 18.81%-22.28M | 153.26%548K | -981.32%-27.44M | -10.76%-1.03M | 84.07%-2.54M | ---929K |
| -Other impairment is provision | 38.12%-10.13M | -30.97%-19.06M | 26.54%-16.37M | -2,755.66%-14.55M | 18.81%-22.28M | 153.26%548K | -981.32%-27.44M | -10.76%-1.03M | 84.07%-2.54M | ---929K |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -7.63%-142.39M | -6.33%-263.31M | -10.87%-132.3M |
| Special items of operating profit | 28.53%581.33M | 6.26%219.44M | -9.10%452.31M | 36.77%206.52M | 54.84%497.61M | -54.18%151M | -65.38%321.36M | -27.12%329.55M | 141.56%928.2M | 167.67%452.18M |
| Operating profit | 12.93%3.39B | 19.41%1.63B | 21.93%3B | 22.38%1.37B | 40.90%2.46B | 40.99%1.12B | -4.29%1.75B | -27.07%791.34M | 9.50%1.82B | 135.73%1.09B |
| Financing cost | 37.64%-324.91M | 38.60%-178.49M | -1.07%-521.02M | -25.14%-290.69M | -95.87%-515.5M | ---232.29M | ---263.19M | ---- | ---- | ---- |
| Share of profits of associates | 31.66%-22.97M | 23.19%-10.82M | -50.15%-33.61M | -41.94%-14.08M | -11.37%-22.38M | -7.84%-9.92M | -769.01%-20.1M | -408.93%-9.2M | 19.02%3M | 172.58%2.98M |
| Share of profit from joint venture company | 36.16%51.35M | 1.89%21.85M | -0.56%37.72M | 89.36%21.44M | 24.06%37.93M | -22.32%11.32M | 59.20%30.57M | 133.18%14.58M | 65.30%19.2M | 28.33%6.25M |
| Special items of earning before tax | -36.58%206.3M | -43.52%107.69M | -8.66%325.29M | 11.22%190.65M | 24.34%356.13M | --171.41M | --286.41M | ---- | ---- | ---- |
| Earning before tax | 17.42%3.3B | 23.41%1.57B | 21.23%2.81B | 20.49%1.27B | 30.15%2.32B | 32.57%1.06B | -3.62%1.78B | -27.20%796.71M | 9.90%1.85B | 137.34%1.09B |
| Tax | -21.94%-525.79M | -28.26%-251.43M | -22.67%-431.18M | -23.48%-196.03M | -41.32%-351.48M | -33.91%-158.76M | 6.63%-248.71M | 19.43%-118.56M | -22.98%-266.36M | -118.66%-147.14M |
| After-tax profit from continuing operations | 16.60%2.77B | 22.53%1.32B | 20.97%2.38B | 19.97%1.08B | 28.34%1.96B | 32.34%897.47M | -3.11%1.53B | -28.40%678.15M | 7.96%1.58B | 140.53%947.2M |
| Earning after tax | 16.60%2.77B | 22.53%1.32B | 20.97%2.38B | 19.97%1.08B | 28.34%1.96B | 32.34%897.47M | -3.11%1.53B | -28.40%678.15M | 7.96%1.58B | 140.53%947.2M |
| Minority profit | 38.13%77.99M | 403.21%42.62M | -7.08%56.46M | -16.72%8.47M | 104.06%60.76M | -50.51%10.17M | -64.10%29.78M | -55.42%20.55M | 22.91%82.94M | 92.23%46.1M |
| Profit attributable to shareholders | 16.08%2.69B | 19.51%1.28B | 21.86%2.32B | 20.39%1.07B | 26.83%1.9B | 34.93%887.3M | 0.27%1.5B | -27.02%657.6M | 7.24%1.5B | 143.67%901.1M |
| Basic earnings per share | 16.30%2.348 | 20.69%1.12 | 22.07%2.019 | 20.36%0.928 | 26.84%1.654 | 35.03%0.771 | 0.38%1.304 | -27.08%0.571 | 7.09%1.299 | 143.93%0.783 |
| Diluted earnings per share | 15.11%2.324 | 20.15%1.115 | 22.07%2.019 | 20.36%0.928 | 26.84%1.654 | 35.03%0.771 | 0.93%1.304 | -26.61%0.571 | 6.78%1.292 | 143.13%0.778 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.